A Randomized, Open-Label, Multi-Center Trial Comparing Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Subjects With Newly Diagnosed Multiple Myeloma
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Dexamethasone; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 15 Dec 2009 Actual end date (1 Oct 2009) added as reported by ClinicalTrials.gov record.
- 15 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Nov 2008 Planned end date changed from 1 Oct 2007 to 1 Sep 2009.